| Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus report M Brunet, T Van Gelder, A Åsberg, V Haufroid, DA Hesselink, L Langman, ... Therapeutic drug monitoring 41 (3), 261-307, 2019 | 525 | 2019 |
| Personalized therapy for mycophenolate: consensus report by the international association of therapeutic drug monitoring and clinical toxicology S Bergan, M Brunet, DA Hesselink, KL Johnson-Davis, PK Kunicki, ... Therapeutic drug monitoring 43 (2), 150-200, 2021 | 119 | 2021 |
| Bupropion increases striatal vesicular monoamine transport KS Rau, E Birdsall, JE Hanson, KL Johnson-Davis, FI Carroll, DG Wilkins, ... Neuropharmacology 49 (6), 820-830, 2005 | 86 | 2005 |
| Blood enzymes and oxidative stress in chronic kidney disease: a cross sectional study KL Johnson-Davis, C Fernelius, NB Eliason, A Wilson, S Beddhu, ... Annals of Clinical & Laboratory Science 41 (4), 331-339, 2011 | 64 | 2011 |
| Persistence of tolerance to methamphetamine-induced monoamine deficits JP Danaceau, CE Deering, JE Day, SJ Smeal, KL Johnson-Davis, ... European journal of pharmacology 559 (1), 46-54, 2007 | 64 | 2007 |
| Age-dependent methamphetamine-induced alterations in vesicular monoamine transporter-2 function: implications for neurotoxicity JG Truong, DG Wilkins, J Baudys, DJ Crouch, KL Johnson-Davis, ... Journal of Pharmacology and Experimental Therapeutics 314 (3), 1087-1092, 2005 | 64 | 2005 |
| A rapid HPLC method used to establish pediatric reference intervals for vitamins A and E KL Johnson-Davis, SJ Moore, WE Owen, JM Cutler, EL Frank Clinica Chimica Acta 405 (1-2), 35-38, 2009 | 47 | 2009 |
| The role of hyperthermia and metabolism as mechanisms of tolerance to methamphetamine neurotoxicity KL Johnson-Davis, AE Fleckenstein, DG Wilkins European journal of pharmacology 482 (1-3), 151-154, 2003 | 46 | 2003 |
| A retrospective analysis of urine drugs of abuse immunoassay true positive rates at a national reference laboratory KL Johnson-Davis, AJ Sadler, JR Genzen Journal of Analytical Toxicology 40 (2), 97-107, 2016 | 45 | 2016 |
| A hybrid approach to urine drug testing using high-resolution mass spectrometry and select immunoassays GA McMillin, SJ Marin, KL Johnson-Davis, BG Lawlor, FG Strathmann American journal of clinical pathology 143 (2), 234-240, 2015 | 40 | 2015 |
| Simultaneous quantification of levetiracetam and gabapentin in plasma by ultra-pressure liquid chromatography coupled with tandem mass spectrometry detection JEM Juenke, PI Brown, KL Johnson-Davis, GA McMillin Therapeutic drug monitoring 33 (2), 209-213, 2011 | 36 | 2011 |
| Therapeutic drug monitoring and dosage adjustments of immunosuppressive drugs when combined with nirmatrelvir/ritonavir in patients with COVID-19 F Lemaitre, K Budde, T Van Gelder, S Bergan, R Lawson, O Noceti, ... Therapeutic Drug Monitoring 45 (2), 191-199, 2023 | 35 | 2023 |
| One hundred false-positive amphetamine specimens characterized by liquid chromatography time-of-flight mass spectrometry SJ Marin, K Doyle, A Chang, M Concheiro-Guisan, MA Huestis, ... Journal of Analytical Toxicology 40 (1), 37-42, 2016 | 34 | 2016 |
| Alterations in vesicular dopamine uptake contribute to tolerance to the neurotoxic effects of methamphetamine KL Johnson-Davis, JG Truong, AE Fleckenstein, DG Wilkins Journal of Pharmacology and Experimental Therapeutics 309 (2), 578-586, 2004 | 34 | 2004 |
| A comparison of two FDA approved lamotrigine immunoassays with ultra-high performance liquid chromatography tandem mass spectrometry JEM Juenke, KA Miller, MA Ford, GA McMillin, KL Johnson-Davis Clinica Chimica Acta 412 (19-20), 1879-1882, 2011 | 31 | 2011 |
| Multigene and Drug Interaction Approach for Tamoxifen Metabolite Patterns Reveals Possible Involvement of CYP2C9, CYP2C19, and ABCB1 JL Powers, SS Buys, D Fletcher, R Melis, KL Johnson‐Davis, E Lyon, ... The Journal of Clinical Pharmacology 56 (12), 1570-1581, 2016 | 30 | 2016 |
| Demystifying analytical approaches for urine drug testing to evaluate medication adherence in chronic pain management GA McMillin, MH Slawson, SJ Marin, KL Johnson-Davis Journal of Pain & Palliative Care Pharmacotherapy 27 (4), 322-339, 2013 | 25 | 2013 |
| Simultaneous UPLC–MS/MS assay for the detection of the traditional antipsychotics haloperidol, fluphenazine, perphenazine, and thiothixene in serum and plasma JEM Juenke, PI Brown, FM Urry, KL Johnson-Davis, GA McMillin Clinica chimica acta 423, 32-34, 2013 | 25 | 2013 |
| Metabolic patterns of fentanyl, meperidine, methylphenidate, tapentadol and tramadol observed in urine, serum or plasma F Wu, MH Slawson, KL Johnson-Davis Journal of analytical toxicology 41 (4), 289-299, 2017 | 23 | 2017 |
| Long‐term post‐synaptic consequences of methamphetamine on preprotachykinin mRNA expression KL Johnson‐Davis, GR Hanson, KA Keefe Journal of neurochemistry 82 (6), 1472-1479, 2002 | 22 | 2002 |
